AI

xAI, the artificial intelligence venture founded by Elon Musk, is currently facing the heat of escalating legal challenges against OpenAI. These developments have not deterred the company’s momentum, however. In a bold move, xAI unveiled upgrades to its flagship Grok 2 chatbot model, showcasing a commitment to innovation despite potential legal repercussions. The juxtaposition of
The energy sector is undergoing profound changes as artificial intelligence (AI) reshapes the dynamics of power generation and consumption. Recent moves by industry giants, such as ExxonMobil, underscore the urgency of meeting the anticipated demand for energy, especially as technology companies ramp up their operations. AI not only enhances efficiency but also forecasts an escalating
In an age where technology swiftly evolves, concerns about child safety and privacy have reached a critical juncture. Texas Attorney General Ken Paxton launches a rigorous investigation into Character.AI and fourteen other platforms to scrutinize their practices regarding child safety and privacy. This initiative highlights growing alarm around how tech companies interact with younger users,
Microsoft has made waves in the field of artificial intelligence with the introduction of its latest generative AI model, Phi-4. This new model is touted as a significant upgrade over its predecessors, particularly excelling in complex mathematical problem-solving. The enhancements in Phi-4’s functionality can be attributed largely to advancements in training data quality and innovative
The Swiss robotics sector is rapidly evolving, with companies like Anybotics leading the charge in innovation and application. Founded in 2016 as a spin-off from ETH Zurich, Anybotics has positioned itself at the forefront of industrial automation through its creation of the Anymal robot—a quadruped autonomous inspection device designed to navigate complex and hazardous environments.
In recent years, the implementation of generative AI in various fields has gained remarkable traction, particularly within the chemical sciences. The landscape of research and development is often characterized by extensive trial and error. Thus, any technological advancement that streamlines this process is not only valuable but essential. One such innovation is Albert Invent, a
In an era where technology and medicine are increasingly intertwined, Aqemia, a dynamic French startup founded in 2019, is leading the charge by harnessing the power of “quantum-inspired physics” and machine learning to revolutionize drug discovery. This ambitious company recently secured $38 million in funding, directed by Cathay Innovation, a prominent venture capital firm based
This week, one of Silicon Valley’s most influential platforms for nurturing startups, Y Combinator, showcased its inaugural Fall cohort during a highly anticipated Demo Day. The event provided a unique opportunity to observe the trends within the tech startup landscape, particularly focusing on the role of artificial intelligence in various sectors. This cohort featured an
In the rapidly evolving world of artificial intelligence, the integration of diverse open-source tools presents both opportunities and significant challenges for businesses. Enter Cake, a fresh startup emerging from stealth mode, offering a streamlined solution for organizations looking to harness AI without getting bogged down by the complexities of infrastructure management. Backed by Google’s AI-focused
China’s emergence as a significant player in the open source artificial intelligence (AI) sector has sparked a blend of admiration and apprehension within the global tech community. With impressive capabilities in tasks such as coding and logical reasoning, Chinese AI models have gained recognition for their performance. However, these advancements have not gone unnoticed; the
As global cancer rates continue to climb, particularly among the younger population, the pharmaceutical industry faces a daunting reality: most drug candidates fail to pass through the arduous process of clinical trials. This observation has sparked significant discourse about the existing methodologies in cancer research, suggesting that the fault may lie not with the drugs
In a significant development within the tech industry, a legal battle has emerged between tech mogul Elon Musk, OpenAI, and its close collaborator Microsoft. Musk’s legal team has filed for a preliminary injunction in the U.S. District Court for the Northern District of California, alleging that OpenAI and key individuals associated with it are engaging